Diamyd Medical AB (DYMDF)
Diamyd Medical Market Cap : 100.37M for June 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Hansa Biopharma AB | 289.23M |
| BioArctic AB | 3.105B |
| Swedish Orphan Biovitrum AB | 16.11B |
| BONESUPPORT HOLDING AB | 1.646B |
| BioInvent International AB | 216.40M |
Market Cap Related Metrics
| PS Ratio | 2451.00 |
| PEG Ratio | -1.359 |
| Price to Book Value | 5.334 |
| Price | 0.73 |
| Earnings Yield | -22.44% |
| PEGY Ratio | -1.359 |